(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.
----------
AIM - WINNERS
----------
Renalytix PLC, up 23% at 349.80p, 12-month range 300.00p-1,220.00p. Launches its new provider access portal, myIntelX. Says new portal will "provide nationwide online access for physicians to order KidneyIntelX bioprognostic testing for more accurate identification of patients at greatest risk for rapid progression of kidney disease in type 2 diabetes patients."
----------
Tissue Regenix Group PLC, up 11% at 0.38 pence, 12-month range 0.36p-0.73p. Signs exclusive distribution agreement with Geistlich Biomaterials Italia, a subsidiary Geistlich Pharma AG, for the distribution of OrthoPure XT in Italy. "The multiyear distribution agreement covers Italy currently but also has the potential for extension to wider geographies. As part of the agreement, Geistlich has also committed to advance the clinical science surrounding OrthoPure XT which will be conducted at some of the leading institutions by clinicians in Italy," company says.
----------
AIM - LOSERS
----------
Gfinity PLC, down 49% at 1.22 pence, 12-month range 1.22p-5.52p. Hits 12-month low as it expects full-year revenue to be below market expectations. Blames slower than anticipated return to live esports events hurting revenue. For first half, ended December 31, expects adjusted operating loss of GBP400,000 versus GBP900,000 loss a year prior. First half revenue to rise to GBP3.3 million from GBP3.0 million. Company adds: "This figure has been impacted by the decision to consolidate the V10 R League, Gfinity's jointly owned digital motorsport property in conjunction with Abu Dhabi Motorsports Management, into a single season taking place in the latter part of the financial year. If revenues relating to this were eliminated from the comparative period, the year on year revenue increase would be 24%."
----------
By Paul McGowan; paulmcgowan@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
Renalytix Plc (RENX)
Tissue Regenix Group (TRX)
Gfinity (GFIN)